[20]
As for the amount of work, it is indisputable that the record was voluminous. There were four patents involved and the record consisted of more than 30 volumes containing 8861 pages. Additional volumes of compendia were submitted during the hearing - 6 for Astra, 6 for Genpharm and 2 for Takeda. The memoranda of fact and law were lengthy - 75 pages for Astra and Genpharm and 34 pages for Takeda. Astra filed 73 authorities; Genpharm filed 39, and Takeda filed 15. While a significant amount of the evidence was imported from three previous proceedings, for which costs have already been awarded, significant additional evidence was added. Volume can be a relevant factor in assessing costs:
Unilever plc
, supra.